Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome.
De Matteis S, Del Coco L, De Castro F, Giudetti AM, Casadei B, Iannotta F, De Felice F, Tomassini E, Vaglio F, Naddeo M, Salamon I, Storci G, Laprovitera N, Messelodi D, Bertuccio SN, Tassoni M, Sinigaglia B, Barbato F, Ursi M, Campanini E, Maffini E, Roberto M, Pellegrini C, Dan E, Pirazzini C, Garagnani P, Ferracin M, Zinzani PL, Fanizzi FP, Bonafè M, Bonifazi F. De Matteis S, et al. Among authors: bonifazi f. Haematologica. 2024 Dec 19. doi: 10.3324/haematol.2024.285154. Online ahead of print. Haematologica. 2024. PMID: 39704157 Free article.
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells.
Storci G, De Felice F, Ricci F, Santi S, Messelodi D, Bertuccio SN, Laprovitera N, Dicataldo M, Rossini L, De Matteis S, Casadei B, Vaglio F, Ursi M, Barbato F, Roberto M, Guarino M, Asioli GM, Arpinati M, Cortelli P, Maffini E, Tomassini E, Tassoni M, Cavallo C, Iannotta F, Naddeo M, Tazzari PL, Dan E, Pellegrini C, Guadagnuolo S, Carella M, Sinigaglia B, Pirazzini C, Severi C, Garagnani P, Kwiatkowska KM, Ferracin M, Zinzani PL, Bonafè M, Bonifazi F. Storci G, et al. Among authors: bonifazi f. J Clin Invest. 2024 Jun 4;134(14):e173096. doi: 10.1172/JCI173096. J Clin Invest. 2024. PMID: 38833312 Free PMC article. Clinical Trial.
Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy.
Pensato U, Pondrelli F, de Philippis C, Asioli GM, Crespi A, Buizza A, Mannina D, Casadei B, Maffini E, Straffi L, Marcheselli S, Zinzani PL, Bonifazi F, Guarino M, Bramanti S. Pensato U, et al. Among authors: bonifazi f. Neurol Sci. 2024 Aug;45(8):4007-4014. doi: 10.1007/s10072-024-07481-0. Epub 2024 Mar 21. Neurol Sci. 2024. PMID: 38512531 Free PMC article.
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity.
Di Staso R, Casadei B, Gentilini M, Guadagnuolo S, Pellegrini C, Broccoli A, Gori D, Masetti R, Stefoni V, Bonifazi F, Zinzani PL, Argnani L. Di Staso R, et al. Among authors: bonifazi f. Ann Hematol. 2024 Jul;103(7):2499-2509. doi: 10.1007/s00277-024-05766-0. Epub 2024 May 2. Ann Hematol. 2024. PMID: 38695872 Free PMC article.
Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy.
Pensato U, Pondrelli F, de Philippis C, Asioli GM, Crespi A, Buizza A, Mannina D, Casadei B, Maffini E, Straffi L, Marcheselli S, Zinzani PL, Bonifazi F, Guarino M, Bramanti S. Pensato U, et al. Among authors: bonifazi f. Neurol Sci. 2024 Aug;45(8):4107. doi: 10.1007/s10072-024-07510-y. Neurol Sci. 2024. PMID: 38573433 Free PMC article. No abstract available.
Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma.
Kuipers MT, Spanjaart AM, Bonifazi F, diBlasi R, Zinzani PL, Thieblemont C, Baudet M, Biemond BJ, Kok WEM, Kersten MJ. Kuipers MT, et al. Among authors: bonifazi f. Leuk Lymphoma. 2024 Mar;65(3):399-402. doi: 10.1080/10428194.2023.2288804. Epub 2023 Dec 9. Leuk Lymphoma. 2024. PMID: 38069804 No abstract available.
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university hospital: Findings after the first year of implementation.
Cojutti PG, Gatti M, Bonifazi F, Caramelli F, Castelli A, Cavo M, Cescon M, Corvaglia LT, Lanari M, Marinelli S, Morelli MC, Pession A, Poggioli G, Ramirez S, Siniscalchi A, Tonetti T, Trevisani F, Zanoni A, Zinzani PL, Gibertoni C, Viale P, Pea F. Cojutti PG, et al. Among authors: bonifazi f. Int J Antimicrob Agents. 2023 Aug;62(2):106884. doi: 10.1016/j.ijantimicag.2023.106884. Epub 2023 Jun 10. Int J Antimicrob Agents. 2023. PMID: 37302773 Free article.
CMV-RNAemia as new marker of active viral replication in transplant recipients.
Piccirilli G, Lanna F, Gabrielli L, Motta V, Franceschiello M, Cantiani A, Pavoni M, Leone M, Borgatti EC, Gibertoni D, Pascale R, Giannella M, Bonifazi F, Lazzarotto T. Piccirilli G, et al. Among authors: bonifazi f. J Clin Microbiol. 2024 May 8;62(5):e0163023. doi: 10.1128/jcm.01630-23. Epub 2024 Mar 27. J Clin Microbiol. 2024. PMID: 38534109 Free PMC article. No abstract available.
330 results